in the nucleus of the solitary tract (NTS) of conscious rats causes hypertension, bradycardia, and vasoconstriction in the renal, mesenteric, and hindquarter vascular beds. In the hindquarter, the initial vasoconstriction is followed by vasodilation with AMPA doses Ͼ5 pmol/100 nl. To test the hypothesis that this vasodilation is caused by activation of a nitroxidergic pathway in the NTS, we examined the effect of pretreatment with the nitric oxide synthase inhibitor N Gnitro-L-arginine methyl ester (L-NAME, 10 nmol/100 nl, microinjected into the NTS) on changes in mean arterial pressure, heart rate, and regional vascular conductance (VC) induced by microinjection of AMPA (10 pmol/100 nl in the NTS) in conscious rats. AMPA increased hindquarter VC by 18 Ϯ 4%, but after pretreatment with L-NAME, AMPA reduced hindquarter VC by 16 Ϯ 7% and 17 Ϯ 9% (5 and 15 min after pretreatment, P Ͻ 0.05 compared with before pretreatment). Pretreatment with L-NAME reduced AMPA-induced bradycardia from 122 Ϯ 40 to 92 Ϯ 32 beats/min but did not alter the hypertension induced by AMPA (35 Ϯ 5 mmHg before pretreatment, 43 Ϯ 6 mmHg after pretreatment). Control injections with D-NAME did not affect resting values or the response to AMPA. The present study shows that stimulation of AMPA receptors in the NTS activates both vasodilatatory and vasoconstrictor mechanisms and that the vasodilatatory mechanism depends on production of nitric oxide in the NTS. nitric oxide synthase; regional vascular conductance; cardiovascular regulation THE PRESSOR RESPONSE and bradycardia elicited by microinjection of L-glutamate into the nucleus of the solitary tract (NTS) of conscious rats are associated with vasoconstriction in the hindquarter, renal, and mesenteric vascular beds. A subsequent vasodilation occurs in the hindquarter bed (4). A similar pattern of an initial general vasoconstriction followed by hindquarter vasodilation can be seen after stimulation of S-␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in the NTS (9). The vasodilation produced by microinjection of glutamate in the NTS can be reduced by systemic administration of prazosin and N G -nitro-L-arginine methyl ester (L-NAME) (4). The origin and pathway involved in this neurogenic vasodilation is still unclear (4), but it was suggested that this vasodilation is caused by peripheral release of preformed nitrosyl factors during sympathetic stimulation (6, 7).Interactions between nitric oxide (NO) and glutamatergic transmission within the NTS on cardiovascular regulation have been shown by anatomic and physiological studies (24,25,27,29,34,36,41). All of the substrates necessary for NO production are present in the NTS. Activation of glutamatergic receptors in the NTS stimulates the production and release of NO and other nitrosyl substances with neurotransmitter/neuromodulator properties (11,34). Microinjection of inhibitors of the enzyme for synthesis of NO, nitric oxide synthase (NOS), reduces the basal glutamate level (24). On the other hand, NO donors, L-arginin...